Pharmaxis Ltd

Press Releases

2012-October-26	Important Milestone Bronchitol Approved by NICE in UK (in PDF)
2012-October-17	Chairman's Address to Shareholders (in PDF)
2012-October-10	Presentation at North American Cystic Fibrosis Conference (in PDF)
2012-October-8	Quarterly Report and Investor Conference Call (in PDF)
2012-September-27	Pharmaxis Receives Maximum Extension to German Patent (in PDF)
2012-August-2	Australian Drug Discovery Listed on the PBS for Cystic Fibrosis (in PDF)
2012-August-2	US FDA Accepts Bronchitol New Drug Application for Review (in PDF)
2012-July-25	Pharmaxis Announces New Board Appointment (in PDF)
2012-July-16	Pharmaxis Quarterly Investor Conference Call (in PDF)
2012-June-25	Pharmaxis Welcomes Bronchitol PBS Listing Announcement (in PDF)
2012-June-8	Additional Data Bronchitol Reduces Risk of Exacerbations (in PDF)
2012-June-1	Bronchitol Commercial Progress in Europe (in PDF)
2012-May-21	Pharmaxis Submits US New Drug Application for Bronchitol (in PDF)
2012-May-1	Pharmaxis Appoints New Chairman (in PDF)
2012-April-20	Pharmaxis Receives Approval to Market Bronchitol in the EU (in PDF)
2012-April-17	Pharmaxis Quarterly Investor Conference Call (in PDF)
2012-April-17	PXS Completes Phase II Study with ASM8 in Asthma Patients (in PDF)
2012-March-29	Pharmaxis Announces Agreement for EU Supply of Bronchitol (in PDF)
2012-March-16	European Regulatiry Update on Bronchitol (in PDF)
2012-March-14	Bronchitol to be Reimbursed in Australia (in PDF)
2012-January-23	Quarterly Investor Conference Call (in PDF)
2017	2017 Press Releases
2016	2016 Press Releases
2015	2015 Press Releases
2014	2014 Press Releases
2013	2013 Press Releases
2011	2011 Press Releases
2010	2010 Press Releases
2009	2009 Press Releases
2008	2008 Press Releases
2007	2007 Press Releases
2006	2006 Press Releases
2005	2005 Press Releases
2004	2004 Press Releases